Niagen Bioscience, Inc. (NAGE)

NASDAQ: NAGE · Real-Time Price · USD

2.070

-0.035 (-1.66%)

At close: Nov 6, 2026, 4:00 PM EST

2.100

+0.030 (1.45%)

After-hours: Nov 6, 2026, 7:41 PM EST

Niagen Bioscience Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	122.29	129.42	99.6	83.57	72.05	67.45
Revenue Growth	-1.94%	29.95%	19.18%	15.99%	6.82%	13.83%
Gross Profit	78.1	83.19	61.59	50.78	42.8	41.49
Operating Income	2.79	14.3	7.73	-5.6	-18.63	-27.07
Net Income	10.24	17.38	8.55	-4.94	-16.54	-27.13
Earnings Per Share	0.12	0.20	0.11	-0.07	-0.24	-0.40
EPS Growth	-48.66%	81.82%	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Consumer Products	97.35	97.67	76.77	69.53	60.11	56.71
Ingredients	23.44	28.68	19.81	11.14	8.74	7.41
Analytical Reference Standards and Services	1.12	3.08	3.01	2.91	3.2	3.34
Total	122.29	129.42	99.6	83.57	72.05	67.45

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	69.36	64.64	44.51	27.17	20.29	28.02
Total Debt	2.08	2.82	2.65	3.28	4.26	4.7
Net Cash (Debt)	67.28	61.82	41.86	23.9	16.03	23.32
Net Cash Growth	10.14%	47.69%	75.16%	49.05%	-31.24%	56.91%
Net Cash Per Share	0.81	0.72	0.54	0.32	0.23	0.35

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	4.88	13.5	12.11	7.12	-15.1	-24.16
Capital Expenditures	-0.3	-0.29	-0.16	-0.15	-0.33	-0.41
Free Cash Flow	4.58	13.21	11.95	6.97	-15.43	-24.57
Free Cash Flow Growth	-78.35%	10.60%	71.42%	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	63.86%	64.28%	61.83%	60.76%	59.40%	61.51%
Operating Margin	2.28%	11.05%	7.76%	-6.70%	-25.85%	-40.14%
Pretax Margin	9.04%	14.06%	8.89%	-5.91%	-22.96%	-40.22%
Profit Margin	8.37%	13.43%	8.58%	-5.91%	-22.96%	-40.22%
FCF Margin	3.74%	10.21%	11.99%	8.34%	-21.42%	-36.43%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	17.17	29.26	47.50	-	-	-
Forward PE	34.97	27.81	50.28	160.00	160.00	160.00
P/FCF Ratio	35.88	38.50	33.99	15.45	-	-
PS Ratio	1.34	3.93	4.08	1.29	1.74	3.79